New ClearPoint Neuro software wins FDA clearance, used in first cases

▤ Summary

ClearPoint Neuro President and CEO Joe Burnett said the system now offers fast, peri-procedural segmentation of the cortical structures of the brain. This helps to identify targets and safety zones for cell and gene therapy delivery, laser ablation, biopsy and deep brain stimulation. Maestro demonstrates superior performance compared to both manual expert segmentation and FreeSurfer, according to quantitative analysis. The company provides both established clinical products as well as preclinical development services for controlled drug and device delivery. The Company’s flagship product, the ClearPoint Neuro Navigation System, has FDA clearance and CE mark.

▦ Linked Companies